Health Care & Life Sciences » Biotechnology | Taxus Cardium Pharmaceuticals Group Inc.

Taxus Cardium Pharmaceuticals Group Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Cash & Short Term Investments
2,378.10
22.50
216.70
21.50
930.40
Total Accounts Receivable
329.00
-
-
-
-
Inventories
1,174.30
159.80
-
-
-
Other Current Assets
407.40
309.20
203.00
9.20
10.40
Total Current Assets
4,288.70
491.50
419.70
30.80
940.80
Net Property, Plant & Equipment
97.60
30.20
16.40
6.50
158.20
Total Investments and Advances
435.00
2,134.70
300.00
-
-
Intangible Assets
2,802.70
-
-
-
-
Other Assets
184.80
130.00
10.00
-
11.80
Total Assets
7,808.90
2,786.40
746.10
37.30
1,110.80
ST Debt & Current Portion LT Debt
-
-
-
946.10
1,050.30
Accounts Payable
777.90
990.30
-
-
-
Other Current Liabilities
614.90
611.00
2,428.00
2,885.50
3,343.30
Total Current Liabilities
1,392.70
1,601.30
2,428.00
3,831.60
4,393.60
Other Liabilities
50.40
-
-
-
6.90
Total Liabilities
1,443.10
1,601.30
2,428.00
3,831.60
4,400.50
Common Equity (Total)
6,365.80
1,185.10
1,681.90
3,794.30
3,137.90
Total Shareholders' Equity
6,365.80
1,185.10
1,681.90
3,794.30
3,137.90
Total Equity
6,365.80
1,185.10
1,681.90
3,794.30
3,289.70
Liabilities & Shareholders' Equity
7,808.90
2,786.40
746.10
37.30
1,110.80
Accumulated Minority Interest
-
-
-
-
151.70

About Taxus Cardium Pharmaceuticals Group

View Profile
Address
11750 Sorrento Valley Road
San Diego California 92121
United States
Employees -
Website http://www.cardiumthx.com
Updated 07/08/2019
Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company . The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease; and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers.